Literature DB >> 32283114

The MID1 gene product in physiology and disease.

Rossella Baldini1, Martina Mascaro1, Germana Meroni2.   

Abstract

MID1 is an E3 ubiquitin ligase of the Tripartite Motif (TRIM) subfamily of RING-containing proteins, hence also known as TRIM18. MID1 is a microtubule-binding protein found in complex with the catalytic subunit of PP2A (PP2Ac) and its regulatory subunit alpha 4 (α4). To date, several substrates and interactors of MID1 have been described, providing evidence for the involvement of MID1 in a plethora of essential biological processes, especially during embryonic development. Mutations in the MID1 gene are responsible of the X-linked form of Opitz syndrome (XLOS), a multiple congenital disease characterised by defects in the development of midline structures during embryogenesis. Here, we review MID1-related physiological mechanisms as well as the pathological implication of the MID1 gene in XLOS and in other clinical conditions.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32283114      PMCID: PMC8011326          DOI: 10.1016/j.gene.2020.144655

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  114 in total

1.  The Opitz syndrome gene MID1 is essential for establishing asymmetric gene expression in Hensen's node.

Authors:  Alessandra Granata; Nandita A Quaderi
Journal:  Dev Biol       Date:  2003-06-15       Impact factor: 3.582

2.  Novel role of Rac-Mid1 signaling in medial cerebellar development.

Authors:  Takashi Nakamura; Takehiko Ueyama; Yuzuru Ninoyu; Hirofumi Sakaguchi; Narantsog Choijookhuu; Yoshitaka Hishikawa; Hiroshi Kiyonari; Masaaki Kohta; Mizuho Sakahara; Ivan de Curtis; Eiji Kohmura; Yasuo Hisa; Atsu Aiba; Naoaki Saito
Journal:  Development       Date:  2017-05-15       Impact factor: 6.868

3.  MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.

Authors:  A Trockenbacher; V Suckow; J Foerster; J Winter; S Krauss; H H Ropers; R Schneider; S Schweiger
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

Review 4.  Emerging Roles and Research Tools of Atypical Ubiquitination.

Authors:  Qiuling Huang; Xiaofei Zhang
Journal:  Proteomics       Date:  2020-01-30       Impact factor: 3.984

5.  The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation.

Authors:  Michele LeNoue-Newton; Guy R Watkins; Ping Zou; Katherine L Germane; Lisa R McCorvey; Brian E Wadzinski; Benjamin W Spiller
Journal:  J Biol Chem       Date:  2011-03-29       Impact factor: 5.157

6.  The Opitz syndrome gene product, MID1, associates with microtubules.

Authors:  S Schweiger; J Foerster; T Lehmann; V Suckow; Y A Muller; G Walter; T Davies; H Porter; H van Bokhoven; P W Lunt; P Traub; H H Ropers
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

7.  GLI3 zinc-finger gene interrupted by translocations in Greig syndrome families.

Authors:  A Vortkamp; M Gessler; K H Grzeschik
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

8.  Solution structure of the MID1 B-box2 CHC(D/C)C(2)H(2) zinc-binding domain: insights into an evolutionarily conserved RING fold.

Authors:  Michael A Massiah; Jessica A B Matts; Kieran M Short; Brandi N Simmons; Suryaparkash Singireddy; Zou Yi; Timothy C Cox
Journal:  J Mol Biol       Date:  2007-03-15       Impact factor: 5.469

9.  Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.

Authors:  J Liu; T D Prickett; E Elliott; G Meroni; D L Brautigan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

10.  Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome.

Authors:  Bijun Li; Tianhong Zhou; Yi Zou
Journal:  Mol Genet Genomic Med       Date:  2015-12-12       Impact factor: 2.183

View more
  5 in total

1.  SPECC1L Mutations Are Not Common in Sporadic Cases of Opitz G/BBB Syndrome.

Authors:  Chiara Migliore; Anna Vendramin; Shane McKee; Paolo Prontera; Francesca Faravelli; Rani Sachdev; Patricia Dias; Martina Mascaro; Danilo Licastro; Germana Meroni
Journal:  Genes (Basel)       Date:  2022-01-28       Impact factor: 4.096

2.  A peculiar family with recurrent self-limited epileptic syndrome and associated developmental disorders in six girls.

Authors:  I Cursio; N Ronzano; M Asunis; M S Dettori; S Cossu; S Murru; M Cau; F Incani; D Mei; C Bianchini; M Scioni; D Pruna
Journal:  Epilepsy Behav Rep       Date:  2022-04-22

3.  Effects of Whole-Body Adenylyl Cyclase 5 (Adcy5) Deficiency on Systemic Insulin Sensitivity and Adipose Tissue.

Authors:  Sebastian Dommel; Anne Hoffmann; Claudia Berger; Matthias Kern; Nora Klöting; Aimo Kannt; Matthias Blüher
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 4.  TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease.

Authors:  Esther L Jones; Stephen M Laidlaw; Lynn B Dustin
Journal:  Front Immunol       Date:  2021-09-06       Impact factor: 7.561

Review 5.  Emerging roles of TRIM27 in cancer and other human diseases.

Authors:  Chengpeng Yu; Dean Rao; Tiantian Wang; Jia Song; Lei Zhang; Wenjie Huang
Journal:  Front Cell Dev Biol       Date:  2022-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.